Histologic Assessment of Non-Small Cell Lung Carcinoma after Neoadjuvant Therapy

Modern Pathology

Volumn 16, Issue 11, 2003, Pages 1102-1108

  Liu Jarin, Xiaolin ^a   Stoopler, Mark B ^a   Raftopoulos, Haralambos ^a   Ginsburg, Mark ^a   Gorenstein, Lyall ^a   Borczuk, Alain C ^a,b  

^a Department of Orthopaedic Surgery   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Lung carcinoma; Neoadjuvant; Non small cell; Pathology; Response

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PACLITAXEL; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FIBROSIS; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MACROPHAGE; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS; TUMOR REGRESSION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FIBROSIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0242691647     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000096041.13859.AB     Document Type: Article

References (23)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumors. 3rd ed. Germany: Springer, 1999.
2. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a cancer and leukemia group B phase II study. J Clin Oncol 1992;10:1237-44.
3. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, et al. Potential impact on survival of improved tumor down-staging and resection rate by pre-operative twice daily radiation and concurrent chemotherapy in Stage IIIA non small cell cancer. J Clin Oncol 1997;15:712-22.
4. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for Stages IIIA and IIIB non-small cell lung cancer: mature results of SWOG Phase II study 8805. J Clin Oncol 1995;13:1880-92.
5. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in respectable IIIA non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-80.
6. Roth JA, Atkinson EN, Fossella F, Komaki R, Ryan M, Putnam JB, et al. Long term follow-up of patients enrolled in a randomized trial comparing peri-operative chemotherapy and surgery with surgery alone in resectable Stage IIIA non-small cell lung cancer. Lung Cancer 1998;21:1-6.
7. Rosell R, Gomez-Codina J, Camps C, Javier Sanchez J, Maestre J, Padilla J, et al. Preresectional chemotherapy in stage IIIA non small cell lung cancer: a 7 year assessment of a randomized clinical trial. Lung Cancer 1999;26:7-14.
8. Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 1993;11:1757-62.
9. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB Jr, Kris MG, Johnson DH, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality lung oncology team. J Thorac Cardiovasc Surg 2000;119:429-39.
10. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small cell cancer. J Clin Oncol 2002;20:247-53.
11. Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, Müller KM. Tumor regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. Cancer Res Clin Oncol 1997;123:469-77.
12. Junker K, Langner K, Klinke F, Bosse U, Thomas M. Grading of tumor regression in non-small cell lung cancer. Morphol Prognosis Chest 2001;120:1584-91.
13. Mountain CF. The International System for Staging Lung Cancer. Semin Surg Oncol 2000;18:106-15.
14. Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Cancer 1985;56:1515-21.
15. Rosen G, Caparros B, Huvos A, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30.
16. Sulfaro S, Frustaci S, Volpe R, Barzan L, Comoretto R, Monfardini S, et al. A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. Cancer 1989;64:994-1001.
17. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemotherapy of esophageal carcinoma. Cancer 1994;73:2680-6.
18. Fushimi H, Kikui M, Morino H, Yamamoto S, Tateishi R, Wada A, et al. Histologic changes in small cell lung carcinoma after treatment. Cancer 1996;77:278-83.
19. Deutsch M, Crawford J, Leopold K, Wolfe W, Foster W, Herndon J, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 1994;74:1243-52.
20. Fowler WC, Langer CJ, Curran WJ Jr, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993;55:986-9.
21. Bonomi P, Faber LP, Warren W, Lincoln S, LaFollette S, Sharma M, et al. Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation. Semin Oncol 1997;24:S12-123-9.
22. Seto M, Kuriyama K, Kasugai T, Kido S, Sawai Y, Kuroda T, et al. Comparison of computed tomography and pathologic examination for evaluation of response of primary lung cancer to neoadjuvant therapy. J Thorac Imaging 1999;14:69-73.
23. Choi NC, Fischman AJ, Niemierko A, Ryu JS, Lynch T, Wain J, et al. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;54:1024-35.